Moreover, during the progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) in breast cancer, the nuclear expression of TET1 and TET2 decreased significantly, accompanied by a reduction in global DNA 5hmC level [21]. The gene discussed is TET2; the disease is ductal breast carcinoma in situ.